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Abstract
Lipopeptides constitute an important class of microbial secondary metabolites. Some
lipopeptides  have  potent  therapeutic  activities  such  as  antibacterial,  antiviral,
antifungal,  antitumor and immunomodulator. Surfactin, iturin, fengycin, lichenysin
and bacillomycin D from Bacillus  species, daptomycin from Streptomyces roseosporus
and  rhamnolipids  from  Pseudomonas  aeruginosa  are  among  the  most  studied
lipopeptides.  These molecules are good candidates to replace those antibiotics and
antifungals  with  no  effect  on  pathogenic  microorganisms.  Microbial  lipopeptides
are produced via fermentation processes by bacteria, yeast and actinomycetes either
on  water  miscible  and  immiscible  substrates.  However,  the  major  bottlenecks  in
lipopeptide  production  are  yield  increase  and  cost  reduction.  Improving  the
bioindustrial  production  processes  relies  on  many  issues  such  as  selecting
hyperproducing strains and the appropriate extraction techniques; purification and
identification  by  Polymerase  Chain  Reaction(PCR),  High  Performance  Liquid
Chromatography-Mass Spectrometry(HPLC-MS),  Matrix  Assisted Laser  Desorption
Ionization-Time  of  Flight-Mass  Spectrometry(MALDI-TOF-MS);  the  use  of  cheap
raw materials and the optimization of medium-culture conditions.  The purpose of
this chapter is to orient the reader on the key elements in this field, including the
selection of  analytical  strategies to get  a good microbial  strain as well  as to show
some examples of  liquid and solid-state  low-cost  fermentation processes.  Last,  we
introduce endophytic bacteria as lipopeptide-producer candidates.
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1. Introduction
In recent years, the production of microbial lipopeptides (LPs) has been widely studied for their
biotechnological application in several areas including pharmaceutical industry, food preser-
vation and agriculture. Lipopeptides are characterized for their highly structured diversity and
their ability to decrease the surface and interfacial tension. Structurally, they consist of a
hydrophilic peptide and a hydrophobic fatty acid acyl chain. The number of amino acids
generally varies from 7 to 25, whereas the length of the fatty acid chains varies from 13 to 17
carbons. One strain is able to produce several isoforms of the same polypeptide. Bacillus- and
Paenibacillus-related lipopeptides (firmicutes) and Pseudomonas-related lipopeptides (Proteo-
bacteria) are the most studied [1,2]. Besides, LPs can also be produced by Streptomyces [3,4] and
fungal strains [5]. The LPs are highly variable and their structural analogues results from frequent
amino acid substitutions. Among the most documented LPs produced by Bacillus strains are
surfactin, iturin, fengycin and lichenysin. On the other hand, those produced by Pseudomonas
strains are viscosin, tensin, arthrofactin, massetolid, pseudodesmin, xantholysin, pseudofactin
and syringomicin. These lipopeptides as many others, are good candidates to replace those
antibiotics and antifungals with no effect on the control of pathogenic microorganisms.
Lipopeptide surfactants are naturally produced as mixtures of several macromolecules
belonging to the same family or class. The nutritional parameters can influence the nature of
the produced LPs [6]. However, the major limitations on their production are the production
costs and yields. A wide range of carbon sources and culture conditions have been reported
in order to increase the production of iturins, surfactins and fengycins. Nowadays, a variety
of cheap raw materials have been used in their production: rice bran, soybean, potato peels,
molasses, etc. In addition, it has been demonstrated that divalent cations have an important
influence on LP production, mainly Mn2+ and Fe2+. The manganese addition to the medium
culture increased yield rates from 0.33 to 2.6 g/L [7]. Furthermore, the presence of ZnSO4,
FeCl3 and MnSO4 increased surfactin production in Bacillus subtilis [8]. In this context, we will
highlight the key parameters for the maximization of LPs production and to development
future strategies for optimizing liquid and solid-state fermentations (SSFs). Both fermentation
types are important on industrial scale production processes.
Another important issue to address here relates to the microbial-producing strains. The genetic
load of the microorganisms is a determining factor on LPs production yields, since the capacity
to generate a metabolite is controlled by genes. There is a need for hyperproducer strains. But
how can we recognize these over producing microbes? Lipopeptides production can be
detected by: (i) culture dependent methods; (ii) methods relying on surface analysis and
emulsifying activity; (iii) cell surface hydrophobicity and (iv) chemical identification [9]. An
optimal and widely accepted study must combine the genetic identification and the structural
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and genetic analysis of the produced LPs by the particular isolate. This methodology assures
the phenotypic and genotypic features of the microbial isolates for LPs production. Currently,
the PCR and gene sequencing are quick tools for screening and identification of microbial-
producers, as well as to identify the genes involved in the LPs synthesis. Also, the isolation
and identification techniques such as liquid chromatography coupled to mass spectrometry
(LC-MS) and more recently the MALDI-TOF mass spectrometry, have been considered as the
fastest and most efficient tools for identification of LPs in mixtures and peptide sequencing,
respectively. These techniques are also useful to identify the most novel LPs and even the small
compositional changes in the sequence of amino acids that will determine its properties. There
is no doubt, that these tools will increase and incentive the development of this field in
fermentation processes.
In our lab, we are particularly interested in bacterial endophytes. By definition, an endophyte
is a bacteria or fungus that lives in the internal tissues of plants without disease manifestation.
Endophytes are ubiquitous to virtually all-terrestrial plants. With the increasing appreciation
of studies that unravel the mutualistic interactions between plant and microbes, functions of
endophytes are gaining value, so these microorganisms have become the target of biotechno-
logical developments for biological control of plant pathogens (fungi and bacteria). We have
evidence that a large group of endophytic bacteria have the ability to eradicate their compet-
itors (pathogens) from the niche using LPs. In this chapter, we are interested in discussing
endophytic microorganisms known as lipopeptide-producers beyond the genus Bacillus. We
believe this information will be of value for alternative research in agricultural microbiology
as well as for the production of antimicrobial molecules. However, given that some endophytic
bacteria have a closer relationship with human pathogens, the application on commercial crops
as biopesticides is strictly regulated. This last point impacts negatively the use endophytic
microbes as tools for disease control and the development of new bioinoculants for agriculture;
therefore, such LPs must be produced by fermentation.
Finally, it must be considered that the production of biosurfactants is associated with the
physiological status of the bacteria, where quorum sensing (QS) is probably a condition.
Quorum sensing is perhaps an overlooked variable in fermentation processes. In this chapter,
we try to explain how this phenomenon and other conditions can alter the performance of LP
production.
2. Lipopeptides: classes, microbial producers, fermentation processes and
downstream processes
2.1. Classes of lipopeptides and their applications
The production of LPs in their active form requires transcriptional induction, translation and
post-translational modifications. The main machinery for their synthesis is multi-modular and
consists of non-ribosomal peptide synthetases (NRPSs) [10]. Synthetases are organized on
modules; each module permits the incorporation of a specific amino acid, subsequent con-
densation, termination and cyclization of the peptide chain. The synthesized peptides contain
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d-amino acids, β-amino acids and hydroxyl- or N-methylated amino acids. The integrated
system introduces heterogeneity among LPs. The peptide moiety is inactive until it is coupled
to a fatty acyl chain. The lipid aliphatic chain, of variable length, fuses with the N-terminal
residue of the peptide chain, and then the bioactive LP is generated. After the biosynthesis of
the LPs is finished, the molecule is modified by glycosylation or halogenation by specific
enzymes associated to the synthetases [11].
Lipopeptides Microbial-producers Activity roles
Surfactin family  Surfactin linchenysin
pumilacidin WH1
fungin 
B. subtilis
B. polyfermenticus
B. megaterium
B. licheniformis
B. pumilus
B. amyloliquefaciens 
-Enhanced oil recovery
Antibacterial
Antiviral
Antimycoplasma
Antitumoral
Anticoagulant
Enzyme inhibition 
Iturin family  Iturin
Bacillomycins
Mycosubtilin
Subtulene (contains a
unique Iso C15-long
chain β -amino acid) 
B. subtilis
B. megaterium 
-Antifungal
-Biopesticides 
Fengycin family  Fengycin
Plipastatin
Agrastatin1 
B. subtilis
B. thuringiensis
B. circulans
B. megaterium 
-Strong fungitoxic agent against filamentous
fungi
-Immunomodulating activities 
Pseudomonas sp.
Lipopeptides 
Viscosin
Massetolide
Entolysin 
Pseudomonas sp  -Antibacterial and Antifungal activity against;
Mycobacterium tuberculosis, Gram positive
bacteria, G. candidum and R. pilimanae 
Streptomyces sp.
Lipopeptides 
Daptomycin  Streptomyces roseosporus -Broad spectrum activity against staphylococci
(MRSA), beta-hemolytic Streptococcus spp.,
Pneumococci, Clostridium spp., and Enterococci sp.
–MRSA
Staphylococcus aureus
-Antiparasitic
-Immunosuppressor 
Table 1. Important and the most studied lipopeptides from Bacillus, Pseudomonas and Streptomyces and their activity
roles.
Many bacteria and some fungi produce LPs, which have several roles including activity against
bacteria, fungi, virus and more recently, it has been discovered their antitumor activity.
Lipopeptides are also are involved in bacterial motility, in the swarming behavior and in the
attachment to surfaces [1]. On the other hand, the extensive use of chemicals to control
pathogens (bacteria and fungi) has modified the behavior of these microorganisms in humans
and plants. The growing drug resistance, in these pathogens, urges for alternative antimicro-
bial molecules for clinical and crop protection, as well as for food preservation. As we men-
tioned above, LPs can be cyclic or linear based on the topology of the peptide chain. Here, we
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present an updated overview on the bioactive LPs and their uses, being the cyclic lipopeptides
the most biologically relevant with proved activity and more market applications in several
fields. The characteristics of the LPs are discussed below, and their properties, structures and
uses have been summarized in Table 1 and Figure 1.
Daptomycin. This structure is a cyclic decanoyl lipid chain attached to 13 amino acids (a 10-
member macrolactone and three exocyclic residues) peptide. It is produced by Streptomyces
roseosporus, a Gram-positive bacterium. It has potent antimicrobial properties and it has been
clinically approved for its use as antibiotic since 2003. It is marketed under the tradename
Cubicin. The mode of action of daptomycin is still unclear, but two hypotheses have been
proposed, the first one states the inhibition of lipoteichoic acid synthesis (proteoglycan
component of the cell wall of Gram-positive bacteria); the second states the disruption of
bacterial membrane potential (depolarization) via pore formation and its calcium ion depend-
ence. Concomitantly, the bacterial cell loses the ability to accumulate amino acid substrates
while leaving glucose uptake intact [12,13]. It has been successfully used to control skin
infections, endocarditis, osteomyelitis and soft-tissue infections [14]. The cost of daptomycin
in the market is approximately €125/day at dose of 6 mg/kg/day.
Surfactin. Surfactins constitute a major class of antibiotic LPs produced by Bacillus spp. They
are highly active biosurfactants able to reduce the surface tension of water to 27 mN m−1 at 20
μmol. This group consist of a heptapeptide bonded to a C13–C15 fatty acyl chain [15]. Surfactins
are able to permeate the lipid membranes as dimer and form ion channels in planar lipid bilayer
membranes. These compounds are effective against Gram-positive and Gram-negative
bacteria and also have antimycoplasma, antiviral and antitumor activity and suppress
inflammatory responses through inhibition of phospholipase A2 [16,17]. Surfactin also inhibits
phytopathogens such as Pseudomonas syringae, Xanthomonas axonopodis, Sclerotinia sclerotium,
Botrytis cinerea, Colletotrichum gloeosporioides and stimulates plant defense [18,19]. Since
surfactins have hemolytic activity their medical applications are limited.
Figure 1. Pharmaceutically and economically important lipopeptides. Structures of representative member of lipopep-
tide synthesized by Bacillus and Streptomyces. (A) Daptomycin, (B) surfactin, (C) iturin and (D) fengycin.
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Iturins. Iturin is an antifungal cyclic lipopeptide produced by Bacillus spp. These amphiphilic
compounds are characterized by a peptide ring of seven amino acid residues including an
invariable d-Tyr2, with the constant chiral sequence LDDLLDL closed by a C14–C17 aliphatic
β-amino acid. Iturins have a high polymorphism due to amino acid variations. These variants
including iturin A, iturin C, iturin D, iturin E, Bacillomycin D, Bacillomycin F, Bacillomycin
Lc, Mojavensin A and mycosubtilin [20]. Iturin A has been shown to form potassium ion-
conducting channels in lipid bilayers. Iturins can act as biocontrol agents of plant pathogens
[14]. They exert their fungicidal action by interacting with sterol components in the fungal
membrane. Mojavensin A, a new member of the family, is cytotoxic [21]. From a clinical
perspective, a disadvantage associated with iturins is their haemolytic activity.
Fengycins. This class of cyclic lipopeptides includes fengycins and plispastatins produced
by some Bacillus and Paenibacillus strains. Fengicins are decapetides acylated with a β-
hydroxylipid tail (C14–C18) and cyclized between the phenol side chain of Tyr 3 and the C-
terminus. They act on plasma membrane of fungal cells and have been suggested for
agriculture. They have antitumor activity because of the production of reactive oxygen species
and mitochondria-dependent apoptosis [22]. They are good candidates for medical applica-
tions due their milder haemolytic activity.
Pseudofactin I and II. These compounds are cyclic octapeptides bonded to palmitic acid
produced by Pseudomonas fluorescens BD5. The C-terminal of the carboxylic group forms a
lactone with the –OH of threonine. Their emulsification activity and stability are greater in
comparison to other synthetic surfactants, thus have a great potential for bioremediation or
biomedicine. For example, Pseudofactin II exerts cytotoxicity in human melanoma [23].
Viscosin is obtained from Pseudomonas fluorescens. It has antibiotic activity, is highly surface
active and is able to inhibit the migration of cancer cells. In Pseudomonas, this LP protects it
from protozoan predation. Viscosin increases the efficiency of surface spreading over plant
roots and protects germinating seedlings in soil infected with plant pathogen [24].
Linear cationic lipopeptides. Limited research has been performed on this small group. This
is surprising as they have the potential to be more accessible than cyclic lipopeptides. This
group includes saltavalin (which was named because contains serine, alanine, leucine,
threonine, valine and 2,4-diaminobutyric acid, isolated from P. polymyxa), jolipeptin (B.
polymyxa), cerexins (B. cereus, B. mycoides), tridecaptins (P. terrae). All exhibit antibacterial
activity against Gram-negative and Gram-positive bacteria.
2.2. Endophytic bacteria as lipopeptide-producers
Due to the nature of the endophytic life style, endophytic microbes establish a long-lasting
stable relationship with the plant. In this symbiotic association, the plant provides nutrients
and shelter for the microbes and, in turn, the endophyte benefits plants by imparting biotic
and abiotic stress tolerance and promoting its growth. Some endophytes are known to produce
anti-pest compounds. These bioactive secondary metabolites can be either directly involved
in antibiosis and/or triggering induced systemic resistance (ISR). There have been published
some reports of the production of LPs by endophytic bacteria that may explain the antifungal
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or antibacterial activity on plant pathogens. Recently, Gond et al. reported an endophytic
Bacillus that produces antifungal LPs and host defense gene expression in maize [25]. Under-
standing the mechanism of biological control helps to manipulate the environment to create
conditions for better biocontrol. Nowadays, in Mexico, some groups are developing research
focused in field applications of LPs rather than bacteria, since many of the bacteria belong to
genera related to human pathogens. In unpublished studies from our group, we have found
strains of bacteria with the ability to produce LPs isolated from plants, including agave, banana
and maize (Beltran-Gracia, manuscript in preparation). In Table 2, we list some of endophytic
strains reported to be lipopeptide-producers.
Endophytic lipopeptide-producers Secreted lipopeptides
B. subtilis  Surfactin  Iturin  Linchenysin 
  Pumilacidin  Bacillomycins  Mycosubtilin 
  Fengycin  Plipastatin   
B. amyloliquefaciens  Surfactin  Linchenysin  Pumilacidin 
  Fengycin     
B. megaterium  Surfactin  Linchenysin  Pumilacidin 
  Iturin  Bacillomycins  Mycosubtilin 
  Subtulene  Fengycin  Plipastatin 
B. circulans  Fengycin  Plipastatin  Iturin 
B. tequilensis  Surfactin  Iturin  Fengycin 
B. polymyxa  Polymyxin 
B. macerans  Surfactin  Iturin  Fengycin 
Streptomyces sp.  Daptomycin 
Pseudomonas sp.  Viscosin  Massetolide  Entolysin 
Table 2. Endophytic bacteria reported as lipopeptide-producers.
2.3. Lipopeptide production by fermentation process: culture conditions and operational
conditions
In order to incorporate LPs into industrial processes and for medical, pharmaceutical and
agricultural uses, it is required their production by fermentation and their posterior down-
stream. It is clear that one of the main limitations for commercial applications of LPs are the
high production costs and the low yield. To overcome these barriers, many efforts have been
focused in improving the fermentation process, which represents a fundamental stage in the
global production. Lipopeptides have been reported as growth-associated metabolites. In
contrast to other bacterial secondary metabolites, production of LPs is induced when the cells
have exhausted one or more essential nutrients, in example, surfactin production is induced
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in actively growing cells during the transition from exponential to stationary phase (SP);
fengycin synthesis is related to the early SP, and iturins only accumulate in the later SP [1].
The production of LPs can be achieved by liquid fermentation (LF) or solid-state fermentation
(SSF) and now, both methods have been proposed for scale up their industrial production. The
LF is an advantageous and typical process used for LPs production in controlled bioreactors,
while SSF is still in evolution but has gained attention owing its priority to LF, including lower
investment for production, less time and higher secondary metabolite yields.
A critical factor into industrial LP production is media optimization. In fact, the nature of the
carbon substrate, N, P, Na, Mg, Fe, Zn and Mn ions concentration in the medium, have been
shown to influence enormously the nature and quantity of the LP produced by several bacterial
strains. An orderly and planned statistical procedure to screen the effect of each component
of the media is very useful. For example, a Plackett-Burman procedure was applied to find that
glucose, K2HPO4, and urea concentrations had the most influence into LPs production by
Bacillus subtilis of 11 tested variables (glucose, urea, ammonium sulfate, NaCl, MgSO4,
KH2PO4, K2HPO4, MnSO4, FeSO4, ZnSO4). After, a Central Composite Design was conducted
to optimize the three selected factors, finding a maximum biosurfactant concentration of 3.1
g/L when using 15 g/L glucose, 6 g/L urea and 1 g/L K2HPO4, keeping the other parameters at
their minimum values [26]. A similar statistical procedure was also applied to determine the
effect of sucrose, ammonium nitrate, NaH2PO4, K2HPO4, MgSO4, MnCl2, extract yeast as
components of culture media to growth Bacillus amyloliquefaciens, using the Plackett-Burman
design in the production of C15-surfactin, indicated a significant effect of sucrose, ammonium
nitrate and NaH2PO4. The optimum values of the tested variables were 21.17 g/L sucrose, 2.50
g/L ammonium nitrate and 11.56 g/L NaH2PO4 with a production of 134.2 mg/L LP [27]. In a
third case, a five-level four-factor Central Composite Design was employed to determine the
maximum LP yield by Bacillus subtilis testing sucrose, ammonium chloride, ferrous sulphate
and zinc sulphate. Optimum fermentation components were 22.431 g/L of sucrose, 2.781 g/L
of ammonium chloride, 6.7879 mM of FeSO4 and 0.0377 mM of ZnSO4 to produce 1.712 g/L of
LP. Only the ammonium chloride had no significant effect [28].
2.3.1. Carbon sources to optimize lipopeptide production
It is clear the importance of carbon source in any fermentation process due to its impact in the
bacterial metabolism as well as in production costs. The nature and quantity of the carbon
source are the most important factors that would affect LPs production. Structural and
compositional diversity of LPs is substrate dependent. For example, Bacillus amyloliquefaciens
was grown in a minimal salt medium with different carbon sources (sucrose, dextrose, maltose,
lactose, glycerol and sorbitol) where a C:N ratio remained constant at 15.55. The surfactin,
iturin and fengycin were detected when dextrose, sucrose and glycerol were used as carbon
source. However, in the presence of maltose, lactose and sorbitol only iturin was produced.
Also, these carbon sources significantly influenced the antifungal activity of the molecules.
Those bacteria grown in media supplemented with dextrose or sucrose produced LPs with the
higher antifungal activity. The maximum biosurfactant activity was observed when the
growing minimal salt medium was supplemented with sucrose [29]. In a similar study, it was
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reported that among several carbon sources: glucose, sucrose, galactose, maltose, sucrose,
glycerol, mannitol, soluble starch and dextrin, evaluated for C15-surfactin production, sucrose
was the best carbon source [27].
2.3.2. Nitrogen sources
Several inorganic nitrogen compounds have been tested in LP production trials, i.e. ammoni-
um nitrate, ammonium sulphate, sodium nitrate, urea and glutamic sodium. And looking for
cheaper raw materials, complex compounds such as soybean flour, peptone and casein acid
hydrolysate have been assayed too [27]. When using organic nitrogen sources it was observed
that tryptone enhances the lipopeptide production because it contains several homologous L-
amino acids to those found in LPs [30]. A similar behavior was reported in the modified Landy
medium, where l-glutamic acid was replaced with various L-α-amino acids at the same
concentration (5 g/L). Cottonseed-derived medium (Pharmamedia) proved to be a suitable
substrate for the production of 220 mg/L of surfactin from Bacillus subtilis; this medium is
suitable to achieve high production yields at low cost, which in turn makes it profitable for
large scale usage. Moreover, supplementing Pharmamedia with Fe2+ (4.0 mM) and sucrose (2
g/L) leads to a maximum production of about (300 mg/L) [31]. Other interesting nitrogen source
is rapeseed meal, a low-cost material that was used to synthetize iturin A by Bacillus subtilis.
The maximum iturin A concentration was 0.60 g/L after 70 h of incubation, which was 20%
and 8.0 times higher than that achieved with peptone and ammonium nitrate media, respec-
tively [32].
2.3.3. Divalent ions
To optimize the trace element composition of culture media the use of statistical experimental
designs is preferred. Such is the case, where was doubled surfactin concentration when was
applied the statistical method Taguchi to determine cation effect of culture medium [33]. The
role of Fe2+ in the synthesis of LPs is crucial; there are some reports where the supplementation
of this cation enhanced the yield of biosurfactants [31,33]. The addition of Fe2+ into fermentation
medium was utilized to optimize surfactin production from Bacillus subtilis, reaching yields
up to 3 g/L into minimal salt medium; the optimal Fe2+ dosage (4.0 mM) leading to 8-fold and
10-fold increments in cell concentration and surfactin yield, respectively, as compared to those
media without Fe2+ [34]. Bacillus amyloliquefaciens in a culture medium supplemented with 0.2
mM of iron was able to produce 92.78 mg/L of iturin after 5 days with no pH control in the
culture. Moreover, if the starting pH at 6.64 and 0.2 mM of ferrous sulphate, an iturin A
production of 121.28 mg/L was obtained [35].
2.3.4. Operational conditions
The pH, temperature, dissolved oxygen concentration and degree of aeration affect cellular
growth, and consequently, biosurfactant production. Optimal operational conditions vary
from strain to strain, and the better growing condition for each particular strain must be
determined experimentally. For example, surfactin synthesis by Bacillus subtilis can be achieved
at temperatures ranging from 25 to 37°C; the optimal temperature for the surfactin produc-
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tion by Bacillus subtilis DSM 3256 was 37.4°C. In contrast, for thermophilic Bacillus spp.
surfactins were produced at temperatures above 40°C without detriment on their activity [36].
Regarding pH, a greater LP activity was observed when the pH was adjusted to between 3.0
and 8.0.
Statistical tools had been used to optimize LP biosynthesis considering operational conditions.
The response surface methodology has been used to determine the maximum LP production
varying the temperature, initial pH and culture cycle. Another important condition to be
controlled is the dissolved oxygen. The oxygen acted at different levels, suggesting a complex
system for regulating the synthesis of LP in B. subtilis ATCC6633. So, the oxygen transfer is
one of the critical parameters for process optimization and scaling-up of production of
surfactin [36]. Varying the oxygen transfer conditions, the synthesis could be oriented to mixed
production or to surfactin monoproduction. The fraction of surfactin towards total LPs
produced and the maximal surfactin production both increased with kLa increase (surfactin
concentration about 2 g/L at kLa = 0.04–0.08 s−1), while the maximal fengycin production
(fengycin concentration about 0.3 g/L) was obtained at moderate oxygen supply (kLa = 0.01 s−1).
The production of LP represents a challenge due to its surface properties. Foam causes a severe
decrease of oxygen transfer. A significant decrease of kLa (up to 27%) was measured during
fermentation process reduces LP biosynthesis [37].
Classical bioreactors aerated by gas bubbling are not suitable for production of LP biosurfac-
tants due to excessive foaming. The use of antifoam agents is not appropriate because it can
affect the bacterial physiology and downstream processing. The alternatives are bioreactor
with foam collector, rotating discs biofilm reactor [38], bubbleless membrane aerated bioreac-
tor [39] and three-phase inverse fluidized bed bioreactor [40]. Another alternative to foam
control is the use of a strictly anaerobic bioreactor cultivation to produce surfactin. Most
interesting, the product yields exceeded classical aerobic fermentations, in which foam
fractionation was applied. Additionally, values for specific production rate surfactin (0.005 g/
(g h)) and product yield per consumed substrate (YP/S = 0.033 g/g) surpass results of comparable
foam-free processes [41]. The bioreactor design is still a challenge to get better productivities
in industrial processes; the LPs synthesis is not an exception.
2.4. Solid-state fermentation (SSF)
Solid-state fermentation (SSF) is an alternative technology for the production of high-value
molecules. The SSF could be an alternative method for the LPs production. The SSF uses agro-
industrial wastes as substrates, which contributes to reduce the production costs. The pro-
ductivity of LPs synthetized by SSF depends on initial moisture content, incubation
temperature, fermentation time, substrates used and supplementary nutrients such as mineral
salts. The temperature is an important parameter for both bacterial growth and LP production.
Within a range from 25 to 40°C, the optimal temperature for growth was found to be 30°C, but
the biosynthesis of LPs is favored at 37°C. At the beginning, in the firsts 24 h, temperature
should be maintained at 30°C, then shifted up to 37°C to enhance LP production [42].
The selection of raw materials to formulate a culture medium, as the previously described,
requires experimental tests. Savings in time and resources can be achieved using statistical
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methods, which help in optimizing components and concentrations in the formulation of a
culture medium. The optimal composition of culture medium in solid-state fermentation to
get the highest LP production had been determined using a ‘Central Composite Design’. First,
a screen to select the major solid substrates was performed, where rapeseed meal, corn flour,
soybean flour, bean cake, wheat bran, rice hull and rice straw were considered as candidates
to support bacterial growth and biosurfactant production. For the election, a quantity of each
solid substrate was supplemented with 1.0 ml of mineral solution with initial pH 7.5 and
moisture content 55%. To increase the porosity of the substrates and improve its availability,
each of them was mixed with an inert substrate (perlite, vermiculite, beads). After that, both
easily digestible carbon sources (glucose, sucrose, starch, l-glutamic, maltose, glycerol, d-
galactose) and nitrogen sources (tryptone, peptone, yeast extract, urea, NH4NO3, NH4Cl,
(NH4)2SO4 at 2% (w/w) were added. The substrates selected to the optimization of the medium
composition for LP production by ‘Response Surface Methodology’ were soybean flour, rice
straw, starch and yeast extract. The optimal conditions were 1.79% starch and 1.91% yeast
extract by employing 5.58 g soybean flour and 3.67 g rice straw as the solid substrate with
initial pH 7.5, moisture content 55% and a 10% inoculum level at 30°C for 2 days. Under these
conditions, the experimental yield of LPs reached 50.01 mg/gram of dry substrates [43]. SSF
many times is compared with submerged fermentation. By this reason, a comparative study
was performed to determine the compositions and properties of LP products purified and the
transcription values of LP genes under submerged fermentation and SSF. Results revealed no
significant differences in the polarity and structure of the two LP products. But, LP obtained
by submerged fermentation possessed higher amino acid proportions, better emulsification
activity and antagonistic activity than that from solid-state fermentation. For solid-state
fermentation, the transcription accumulation levels of the LP synthetic genes srfA and sfp were
higher than for submerged fermentation at the same stage. Transcripts for ituD and lpa-14
remained elevated for a longer period of time under solid-state fermentation conditions,
accounting for differences in the production and fermentation periods between both fermen-
tation techniques [44].
2.5. Downstream processing: isolation and purification of lipopeptides from fermentation
process
Due to different applications of LPs, we need different levels of purity. Crude LPs can straight-
away be used in bioremediation related applications, where the overall economy of the process
is the most important concern. On the other hand, partially purified fractions (about 60–80%
pure) can suit applications in microemulsion based nanoparticle synthesis, laundry and food
industry. However, the requirement for ultrahigh pure product is indispensable, if the LPs are
to be considered for pharmaceuticals and human healthcare [45]. As we mentioned before, the
intense foaming produced during aerobic liquid fermentation is a big obstacle for the com-
mercialization making their recovery and purification difficult. A great deal of monetary input
will be required for purification, this account 60% of the total production cost. Different
techniques have been developed to extract and purify LPs. Among the most used techniques
to extract are acid precipitation (HCl 6N), solvent extraction (chloroform, ethyl acetate,
dichloromethane or mixtures of chloroform-methanol), ammonium sulphate precipitation
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with dialysis to remove small molecules and salts, and foam fractionation (utilized for
continuous retention process and high purity). For purification normally have been used
membrane ultrafiltration techniques, ionic exchange chromatography and adsorption-
desorption on resins (XAD-4, XAD-7 HP, HP-2MG, HP-20) or activated carbon. The High
Performance Liquid Chromatography(HPLC) (an excellent method for separation of this class
of molecules) uses a reverse phase with C18 columns. The LPs separated can be detected using
ultraviolet absorbance or diode arrays detectors and each peak separated is collected using a
fraction collector for further analysis of their structure.
2.5.1. Example of techniques used for lipopeptide recovery, purification and identification
Membrane ultrafiltration. This technique serves essentially as an intermediate process for the
recovery and purification of LPs. The separation of LPs by membrane filtration depends on
their molecular aggregation behavior and on their ability to form micelles, since a process
become economic feasible when a high MWCO (molecular weight cut-off) membranes were
used. In general, the use of low MWCO membranes requires high maintenance due to low
permeate fluxes through smaller pores that get easily plugged by monomers and progressive
reduction in flux caused by the mechanism of concentration polarization [45].
A two-step ultrafiltration process using large pore size membranes (up to MWCO = 300 kDa)
was investigated to separation of LPs aggregated in single and mixed solutions from fermen-
tation culture. In single solutions of LP both surfactin and mycosubtilin formed micelles of
different size depending on their concentration. However when the LPs were in the same
solution, they formed mixed micelles of different size and probably conformation to that
formed by the individual LPs, this prevents their separation according to size. An effective
rejection in the first ultrafiltration step was achieved by membranes with MCWO= 10–100 kDa
but poor rejection by the 300 KDa membrane [46]. The rejection is a measure of retention
capacity of a membrane. However, some properties of LP micelles such as poor stability and
non-uniform size distribution limit the use of readily scalable high MWCO membranes for the
purification of LP, as smaller sized micelles and monomers can easily pass through the pores
of these membranes. An addition of Ca2+ ions causes the structural transformation of surfactin
monomers to larger micellar aggregates, showing excellent features such as compact structure,
narrow size distribution, and improved stability [45].
Chromatographic technique for daptomycin. Daptomycin was purified from clarified
fermentation broth using anion exchange chromatography and reverse phase chromatogra-
phy. The anion resin was a highly cross-linked agarose with dextran surface extender. Dapto-
mycin was eluted from the anion exchange column with a NaCl gradient from 0.2 to 1.0 M in
water. The semi-purified daptomycin was then added to a reversed phase column and was
washed with water containing 15% of alcohol. The reverse phase resin was a mono-sized,
porous resin made of polystyrene and divinyl benzene (source: RPC 30). After, daptomycin
was eluted with 40–70% of ethanol. Two reverse phase columns were involved to improve the
purity of the final product at different pH. The first column was run at pH 7.5–8.0, while the
second one was eluted at pH 3.0–3.1. The purified daptomycin is then filtered and lyophilized
under standard conditions with at least 95% of purity [47].
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Resins. Macroporous adsorption resin (MAR) chromatography has been successfully used for
separation of bioactive molecules on the basis of hydrophobic/hydrophilic interactions
between solute and resin surface. MAR has been resolved problems related with low efficiency
to separate LP mixtures into individual families employing a simple stepwise solvent gradient
elution under optimal conditions. The adsorption and desorption of solutes on MARs depend
upon the properties of the resins such as particle size, pore diameter, surface area and polarity.
An example is the performance of a non-polar resin (HP-20) that combine features such as
higher surface area, pore size and appropriate polarity, allowing it to have a superior adsorp-
tion capacity over other resins. Dual gradient MAR was applied to a cell free broth diluted
until its total crude LP concentration was 3 g/L, then it was pumped at a flow rate of 1 ml/min
into the column pre-packed with HP-20 resin (15 g) until breakthrough point. After one run
of adsorption and desorption, the three LP families were successfully enriched in separate
fractions and the recovery yields were 79.5% for iturin, 94.4% for fengycin and 89.4% for
surfactin. Their purities in the enriched fractions were found to be 68.3, 77.6 and 91.6%,
respectively. This process represents a basis for in situ recovery of LPs from the culture broth
in continuous mode [48].
2.5.2. HLPC-MALDI-TOF
HPLC is an excellent method for the separation of individual LP separation. The most
employed technique is reverse phase chromatography, due to this method can separate this
metabolite based on its polarity. The separated products are detected by UV absorbance
detection and each individual peak can be collected for further analysis of their structure. Also,
use of a diode array detector is recommended. This detector can measure simultaneous
wavelengths in a range of 200–600 nm, this means that we can detect LPs as they are eluted
from the column in several wavelengths. For mobile phases reported, the methanol:water
(80:20) is the most commonly employed, due this phase can elute several LPs as fengicins and
iturins. Also, another mobile phase used is acetonitrile:water, as the methanol:water phase,
this mobile phase can elute LPs as surfactins. The proportions for a acetonitrile:water can
change depending on the LP that you want to separate. The typical column for LP’s separation
is a C-18 column, the length can vary from 150 to 250 mm, and this depends on the resolution
and separation desired. In terms of particle size, 5 μm is the most adequate for the stationary
phase. Table 3A shows some conditions of HPLC most widely used for separation as well as
quantification of LPs derived from a fermentative process [49,50].
MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) is a mass spectrome-
try technique that allows the identification of intact compounds. Samples to be analyzed are
mixed with a matrix and dried on a stainless steel plate, onto which a laser with various degrees
of energy is fired to forming gaseous ions, which can be separated in a time of flight (TOF)
analyzer and detected. Now, MALDI-TOF-MS has come to be regarded as a very fast and
reliable tool for identification of LPs when compared to the conventional methods like
culturing and purifying the LPs. The MALDI-TOF-MS for the identification of LPs has been
previously reported [51, 52]. For LP identification, we can use CHCA (α-cyano-4-hydroxycin-
namic acid), SA (sinapic acid) and DHB (2,5-dihydroxybenzoic acid). To the best of our
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knowledge, DHB matrix is better than CHCA, because we obtain a good quality spectra with
intensities above 2E4 and LP isomers can be observed. In Table 3B are shown relevant
information of the mass range for specific LPs identification derived from MALDI-TOF
analysis.
TECHNIQUE CONDITIONS LIPOPEPTIDE
SEPARATED
(A) HPLC COLUMN C-18, 150mm–
250mm length,
size particle 5μm
ITURIN,
FENGYCIN
SURFACTIN
AMPHISIN
LOKISIN
HODERSIN,
TENSIN
VICOSINAMIDE
DAPTOMYCIN
VISCONSIN
MASSETOLIDE
ENTOLYSIN
MOBILE PHASE Methanol: water
(80:20),
Acetonitile:water
(80:20 and 40:60),
acetonitrile: acetic
acid (68:32)
RETENTION
TIMES
3-10 min iturin
10-16 min fengycin
16-25 min surfactin
28.5 min amphisin
29 min lokisin
29.2 min hodersin
29.9 min tensin
31.6 min vicosinamide
DETECTORS UV-VIS (205, 235,
278, 285nm), diode
array.
(B) MASS
SPECTROMETRY
PEAKS (m/z) IDENTIFICATED
LIPOPEPTIDE
1001.42, 1029.42;
1016.56, 1030.58,
1044.59, 1058.61,
1072.62; 1030.64,
1044.65, 1058.66,
1072.67
ITURIN A
1052.63,1094.45,
1122.47, 1136.55;
1052.64, 1066.57;
1052.62, 1066.60,
1080.59
BACILLOMYCIN
1435.58, 1449.63,
1463.68 , 1477.66;
1421.61, 1435.66,
1459.69, 1463.71,
1477.72; 1421.75,
1435.76, 1449.77,
1463.79, 1477.60,
FENGYCIN
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TECHNIQUE CONDITIONS LIPOPEPTIDE
SEPARATED
1491.81
1488.70, 1502.71,
1516.62; 1488.71,
1502.72; 1488.79,
1502.79
FENGYCIN
(POTASSIUM
ADDUCT)
1074.58, 1088.57,
1102.55
BACILLOMYCIN
(SODIUM
ADDUCT)
1485.70 ,
1499.71, 1513.71;
1471.75, 1485.76,
1499.77, 1513.79
FENGYCIN
(SODIUM
ADDUCT)
878.47, 892.41,
906.50
KURSTAKINS
1202.75, 1188.73,
1143.70, 1129.68,
1168.77, 1154.75
POLYMYXINS
1421.75, 1407.73,
1393.72, 1379.70
BACITRACINS
Table 3. HPLC strategies and conditions (A) used for lipopeptides separation from extracts of culture filtrate and (B)
ranges of m/z of typical peaks obtained by MALDI-TOF analysis. In bold, the reference peaks for lipopeptide
identification.
2.6. Discovery of endophyte-producers of lipopeptides: combining molecular biology and
chromatographic- mass spectrometry methods
To search for endophytic bacteria in nature that can produce LPs, researchers must optimize
their screening and identification times. Actually, the strategies for the selection of endophytic
microorganisms as candidates for biocontrol or lipopeptide-producers combines antifungal-
antibacterial screenings, a molecular analysis of the genes involved in the LP synthesis and
then an analysis of the extracts obtained from the culture medium by HPLC and mass
spectrometry.
In practice, after endophyte isolation, we identify the purified strain by MALDI-TOF and
confirm its identity by 16s rDNA sequencing. Once identified, we select the strain as a function
of its antagonistic ability against plant pathogenic strains. For screening antifungal activity of
the isolates, we use a dual culture test against fungal strains collected from plants and
previously identified. Normally, the plates are incubated for 3–5 days to observe inhibition of
the fungal mycelium (Figure 2). For screening the presence of LP product biosynthetic gene
clusters present in the antifungal isolate, PCR-based screening methods are used for different
genes involved. In Table 4, we show the summarized sequences and methods for PCR analysis
most used for some lipopeptide-genes, then each amplification product is analyzed by agarose
gel electrophoresis to compare the predicted base-pair number (Figure 3). The sequence data
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obtained must be analyzed by BLAST and detailed in silico phylogenetic analysis to confirm
the PCR product.
Figure 2. Antagonism of endophytic Bacillus subtilis (Bs), B. amyloliquefaciens (Ba) and B. tequilensis (Bt), Kocuria marina
(Km) and Lysinibacillus fusiformis (Lf) isolated from agave, banana and maize against Rhizotocnia sp. and Colletotrichum
sp. incubated by 5 days. It is noted that Bacillus strains used are the only ones that have antifungal activity, so the other
strains should be discarded for identification analysis.
LIPOPEPTIDES  GENES PRIMERS  PRIMERS SECUENCES (5′–3′) AT*  PCR++
Iturin  ituD
ituC
ituA 
ITUD-F1
ITUD-R1
ITUC-F1
ITUC-R1
ITUD1F
ITUD1R 
TTGAAYGTCAGYGCSCCTTT
TGCGMAAATAATGGSGTCGT
CCCCCTCGGTCAAGTGAATA
TTGGTTAAGCCCTGATGCTC
GATGCGATCTCCTTGGATGT
ATCGTCATGTGCTGCTTGAG 
55
55
55 
482
594
647 
Surfactin  srfA
srfP
srf/Ich 
SRFA-F1
SRFA-R1
SFP-F1
SFP-R1
As1-F
Ts2-R 
AGAGCACATTGAGCGTTACAAA
CAGCATCTCGTTCAACTTTCAC
ATGAAGATTTACGGAATTTA
TTATAAAAGCTCTTCGTACG
CGCGGMTACCGVATYGAGC
ATBCCTTTBTWDGAATGTCCGCC 
55
52
43 
626
675
428 
Mycosubtilin  Myc/itu  Am1-F
Tm1-R 
CAKCARGTSAAAATYCGMG CCDASATCAAARAADTTATC  45  419 
Fengycin  fen  Af2-F
Tf1-R 
GAATAYMTCGGMCGTMTKGA GCTTTWADKGAATSBCCGCC  45  452 
Piplastin  pps  Ap1-F
Tp1-R 
AGMCAGCKSGCMASATCMCC
GCKATWWTGAARRCCGGCGG 
58  1029 
*AT: ANNEALING TEMPERATURE (°C).
+PCR: PCR PRODUCT SIZE EXPECTED (bp).
Table 4. PCR primers commonly used for amplification of lipopeptide genes.
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The crude extracts obtained from culture media must be subject to HPLC separation and their
collection for mass identification. The chromatographic profile of acidic methanol extracts and
MALDI-TOF spectra of LPs from endophytic Bacillus amyloliquefaciens and B. tequilensis shown
the presence of LPs groups iturins, fengycins and surfactin (Figure 3). Mass ranges (m/z) are
1001.42–1072 for iturin, 1471–75–1513.79, 1488.70–1516.62 for K and Na adducts of fengycin
respectively and 1000–1100 for surfactin.
Figure 3. Agarose gel electrophoresis of PCR products of Bacillus endophytes (Below left) and separation and identifi-
cation of the antifungal lipopeptides from acidic methanol extract by using reversed-phase HPLC(Above left) and
MALDI-TOF MS analysis (Right) Section 2: PCR detection of lipopeptide and biosynthesis genes from Bacillus amyloli-
quefaciens (A), B. tequilensis (B), B. subtilis (C). M DNA ladder, Lane 1 Subtilosin, Lane 2 Sublancin, Lane 3 Plipasta-
tin, Lane 4 Iturin D, Lane 5 Iturin C, Lane 6 Iturin A, lane 7 Surfactin A, Lane 8 Surfactin F, Lane 9 Mycosubtilin, Lane
10 Fengycin, lane 11 Subtilin A Lane 12 Ericin and Lane 13 Surfactin P. Chromatogram profile and MALDI-TOF mass
spectrum of B. amyloliquefaciens (A) and B. tequilensis (B). The chromatograms were obtained under the following con-
ditions: 0-3min: 45%-50% acetonitrile; 3-8min: 50%-80% acetonitrile; 8-25min: 80-100% acetonitrile, temperature of 38°C
and a C-18 column (5μm particle size, 250 mm). Mass spectra were obtained with a RP 700-3500 Da, DHB as matrix. In
section 1 (A1 and B1), we can observe the mass spectrum of the HPLC fraction collected (within 4 min for A1 and 5
min for B1) that represent iturin (Section 3: with mass of 1016.68m/z and surfactin (1065.06 m/z) indicated that both
strains produce this lipopeptides. In A2 and B2 we observe fengycin, in both cases the mass spectrum contains the rep-
resentative mass of fengycin (1477 m/z) in section 3.
2.7. Quorum sensing in fermentative processes and lipopeptide production
Quorum sensing (QS) is a form of cell-cell communication by which bacteria communicate by
secreting signaling molecules called autoinducers that help regulate gene expression. The QS
molecule as N-acylhomoserine lactones in Gram-negatives or AIP in Gram-positives regulates
different bacterial functions such as antibiotic biosynthesis, production of virulence factor,
bacterial swarming, sporulation, competence and transition to the stationary growth phase.
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How are LP production and quorum sensing associated? Surfactin a LP widely mentioned in
this chapter book was proposed as a quorum-sensing molecule that activates the process of
sporulation and production of biofilm [53]. For regulation of surfactin production by a cell
density-responsive mechanism B. subtilis utilized a peptide pheromone Com X. Com X
accumulates in the growth medium. So, the QS control the srf operon expression via Com X.
However, few studies have been reported relating QS with fermentative processes. The
production of putisolvins, also cyclic lipopeptides, in Pseudomonas putida occur at the end of
the exponential growth phase, which indicates that the production of putisolvins is mediated
through a quorum sensing-mechanism [54,55]. Another example that links QS with LP
production is rhamnolipid a glycolipid biosurfactant produced also by Pseudomonas spp. The
rhl quorum sensing system in P. aeruginosa regulates the production of rhamnolipid type
biosurfactants. RhlA, a rhamnosyltransferase, catalyses the synthesis of fatty acid dimers that
subsequently serve as the precursor for RhlB to form monorhamnolipids and dirhamnolipids
catalyzed by RhlC. The genes (rhlA, rhlB and rhlC) for these catalyses are under the control of
QS. Other studies link rhamnolipids synthesis to nutritional conditions, such as nitrogen
exhaustion and the alternative sigma factor σ54 for nitrogen limitation. Schmidberger et al. [56],
reports an interesting study of P. aeruginosa and rhamnolipid synthesis. Using PCRq, gene
expression was monitored over entire course of fermentation. They observed until late
deceleration phase (or ending log phase), an increase in relative gene expression of the las, rhl
and pqs quorum-sensing regulon under nitrogen limitation.
Fermentation processes in terms of batch fermentation constituted a molecular black box in
regards to transcriptional activity of the genes of LP synthesis circuitry in both Gram-positive
and Gram-negative bacteria. More studies of the molecular biology during fermentation of
LPs are needed. Monitoring gene expression of LPs over the entire time course of the fermen-
tation process provides information about regulatory events linked or not to QS. QS is a
variable that has largely been ignored in fermentative process studies. It is likely that infor-
mation on QS in fermentation will help optimize bioreactor conditions, nutrient limitations or
perhaps the use of signal molecules of QS to improve production yields of LPs and other
microbial products.
3. Conclusions
The examples discussed so briefly in this chapter are by no means exhaustive. Hopefully they
serve to illustrate the potential use of bacterial LPs and highlight potential applications in fields
of biomedicine and agriculture. We also emphasize the potential of endophytic bacteria as
lipopeptide-producers, opening research opportunities to understand some of the mecha-
nisms involved in the biological control that occurs in niches they inhabit as endophytes.
Knowledge of this and other topics, will promote the implementation of new molecules that
are harmless to humans when we cannot directly apply bacteria in agricultural fields. It is clear
that for widespread use of microbial LPs, more research is required focused on production
with higher yields and at lower cost, where solid-state fermentation emerges as an important
area of study in fermentation processes. This field is very much in its early stages, and progress
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will come from a combination of ecological, physiological, structural, genetic and fermentative
process approaches.
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